HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 204 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $668,882 | +99.1% | 17,510 | +129.2% | 0.20% | +17.9% |
| Q2 2022 | $336,000 | +122.5% | 7,639 | -25.9% | 0.17% | +110.0% |
| Q4 2018 | $151,000 | -53.7% | 10,313 | -42.6% | 0.08% | -43.7% |
| Q3 2018 | $326,000 | +34.2% | 17,965 | +44.5% | 0.14% | +140.7% |
| Q1 2018 | $243,000 | -68.7% | 12,429 | -67.6% | 0.06% | -74.1% |
| Q4 2017 | $777,000 | +164.3% | 38,345 | +126.9% | 0.23% | +174.7% |
| Q3 2017 | $294,000 | – | 16,900 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |